This is further evidenced by decreased levels of aspartate (M + 3), derived from pyruvate anaplerosis, and of carbamoyl aspartate, carbamoyl phosphate, and dCytidine in CNP treated PAH pericytes. This evidence concerns the gene CNP and pulmonary arterial hypertension.